Just now, the second batch of drugs in Zhejiang Province lowered the online transaction price, and 1 drug was suspended without price reduction

Just now, Zhejiang Pharmaceutical Machinery centralized purchase network released the notice on the result of price complaint handling of the winning products of Zhejiang Pharmaceutical centralized purchase (the second batch in 2019), involving 2 varieties (3 product specifications) of 2 enterprises According to the notice, during the execution of the national minimum price linkage result of drug online trading products in Zhejiang Province, some products were complained due to price and other reasons According to the relevant provisions of drug centralized purchase in Zhejiang Province, through the procedures of verification and publicity, and through research, it was decided that Shandong new era tegio capsule (specification: tegafur 20mg, gemetidine 5.8mg, etc.) would be lowered from now on, At the same time, Shandong new era's tegio capsule (specification: tegafur 20mg, gemeline 5.8mg, otilachium 19.6mg) was suspended because it did not agree to the price reduction The following is the original text of the notice: all relevant medical and health institutions, distribution enterprises and bidders: in the implementation of the national minimum price linkage results of drug online trading products in our province, some products were complained about due to price and other reasons According to the relevant provisions of centralized drug purchase in our province, through the procedures of verification and publicity, through research, it is decided to reduce the online transaction price of tegio capsule and other products from now on, and suspend the online transaction qualification of products that do not agree to the price reduction See the annex for details Notice is hereby given Attachment: Catalogue of products involved in online transaction.pdf Zhejiang Pharmaceutical Machinery Procurement Center May 21, 2019